CRIS Current Research Information System

BARTESAGHI, RENATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.369
EU - Europa 2.584
AS - Asia 1.222
AF - Africa 260
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.356
GB - Regno Unito 662
IT - Italia 617
CN - Cina 450
DE - Germania 381
SG - Singapore 323
SE - Svezia 299
VN - Vietnam 224
TG - Togo 129
IN - India 126
UA - Ucraina 122
IE - Irlanda 102
FR - Francia 89
RU - Federazione Russa 73
CH - Svizzera 63
ZA - Sudafrica 54
JO - Giordania 45
BG - Bulgaria 43
EE - Estonia 43
CI - Costa d'Avorio 35
BE - Belgio 28
NG - Nigeria 28
NL - Olanda 22
IR - Iran 15
CA - Canada 13
SC - Seychelles 13
JP - Giappone 10
FI - Finlandia 9
GR - Grecia 9
ID - Indonesia 6
PL - Polonia 5
TR - Turchia 5
AU - Australia 4
BR - Brasile 4
ES - Italia 4
LB - Libano 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
HK - Hong Kong 2
HR - Croazia 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
DK - Danimarca 1
IL - Israele 1
KR - Corea 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.446
Salva come PNG Salva come JPEG
Città #
Southend 581
Fairfield 565
Chandler 512
Ashburn 317
Singapore 296
Houston 274
Woodbridge 266
Wilmington 262
Seattle 247
Santa Clara 233
Ann Arbor 211
Bologna 210
Cambridge 201
Dong Ket 153
Princeton 147
Lomé 129
Dublin 102
Boardman 90
Jacksonville 78
Nanjing 59
Westminster 59
Bern 56
Padova 53
Falls Church 52
Turin 51
Amman 45
Berlin 43
Frankfurt am Main 43
Sofia 43
Beijing 41
Redmond 36
San Diego 36
Abidjan 35
Shenyang 34
Abeokuta 27
Brussels 27
Saint Petersburg 26
Jinan 23
Hebei 21
Nanchang 20
Milan 19
Changsha 16
Dearborn 16
Mülheim 16
Redwood City 15
Tianjin 15
Des Moines 12
Florence 12
Mahé 12
New York 12
Taizhou 12
Trento 12
Bremen 11
Guangzhou 11
Rimini 11
Shanghai 11
Toronto 11
Ardabil 10
Bristol 10
Norwalk 10
Rome 10
Helsinki 9
Olalla 9
Zhengzhou 9
Meldola 8
Wuhan 8
Haikou 7
London 7
Monmouth Junction 7
Udine 7
Hangzhou 6
Jakarta 6
Los Angeles 6
Naples 6
Ravenna 6
Bühl 5
Chicago 5
Forlì 5
Jiaxing 5
Kunming 5
Lanzhou 5
Marano 5
Paris 5
Piemonte 5
Pune 5
San Giorgio di Piano 5
Taiyuan 5
Tokyo 5
Argelato 4
Bolzano 4
Chengdu 4
Frankfurt Am Main 4
Hyderabad 4
Kuban 4
Leawood 4
Mountain View 4
Munich 4
Parma 4
Phoenix 4
Qingdao 4
Totale 6.182
Salva come PNG Salva come JPEG
Nome #
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 238
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 174
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 172
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 165
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 158
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 157
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 156
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 156
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 155
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 151
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 151
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 150
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 144
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 144
Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice 139
Neurochemical correlates of nicotine neurotoxicity on rat habenulo-interpeduncular cholinergic neurons. 138
Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn Mouse, an animal model for Down syndrome. 138
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 138
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 138
Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. 137
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 135
Postnatal neurogenesis in the dentate gyrus of the guinea pig 134
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 133
Cyclic AMP-mediated regulation of transcription factor Lot1 expression in cerebellar granule cells. 132
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 131
null 130
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 128
Topographic activation of the medial entorhinal cortex by presubicular commissural projections. 127
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 127
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 125
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 125
Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea pig before puberty 123
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 120
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 120
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 120
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 120
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 119
Effect of early isolation on signal transfer in the entorhinal cortex-dentate-hippocampal system 118
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 118
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 117
Timing of therapies for downsyndrome: The sooner, the better 117
Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in newborn rat. 116
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 114
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 111
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. 110
Parallel activation of field CA2 and dentate gyrus by synaptically elicited perforant path volleys. 108
Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. 106
Sex differences in the hilar mossy cells of the guinea-pig before puberty. 105
Is it possible to improve neurodevelopmental abnormalities in Down syndrome? 104
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 101
null 100
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 100
null 97
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 96
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 95
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 93
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 91
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 91
Effect of early isolation on the synaptic function in the dentate gyrus and field CA1 of the guinea pig. 88
Effects of early environment on field CA2 pyramidal neurons in the guinea-pig 87
Targeting APP/AICD in Down syndrome 87
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 85
Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Goettingen minipig. 84
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome 84
null 83
Input-output relations in the entorhinal cortex-dentate-hippocampal system: evidence for a non-linear transfer of signals. 81
New perspectives for the rescue of cognitive disability in down syndrome 76
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 59
Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down sindrome 50
Neurogenesis impairment: An early developmental defect in Down syndrome 49
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 47
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 42
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives 38
Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty 24
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 22
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 19
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 16
Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig 14
Effects of early isolation on layer II neurons in the entorhinal cortex of the guinea pig 12
Sex differences in the hilar mossy cells of the guinea-pig before puberty 11
Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide 10
Totale 8.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.636 0 0 0 0 216 222 267 288 311 146 90 96
2020/20211.193 189 99 25 113 20 78 17 78 98 90 56 330
2021/20221.366 82 55 92 84 145 94 81 80 57 93 250 253
2022/20231.896 171 364 108 253 111 151 56 84 283 29 137 149
2023/2024489 29 83 29 50 38 100 14 22 8 36 49 31
2024/2025968 118 214 143 168 325 0 0 0 0 0 0 0
Totale 8.624